ACA
IMTX icon

American Capital Advisory’s Immatics IMTX Stock Holding History

American Capital Advisory’s Portfolio IMTX Stock Details IMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6
Closed -$69 – 490
2024
Q3 		$69 Buy
+6
New +$71 ﹤0.01% 462

Other funds holding IMTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

American Capital Advisory's IMTX Position: Q4 2024 in Review

American Capital Advisory sold out of Immatics (IMTX) in Q4 2024, closing a stake of 6 shares — an estimated $69 sold.

American Capital Advisory first reported a position in IMTX in Q3 2024 and held it in 1 quarter. The position peaked at $69 in Q3 2024. 85 funds tracked by Wall St. Rank hold IMTX as of Q4 2024.

  • American Capital Advisory reported no remaining Immatics position as of Q4 2024 after selling out during the quarter.
  • American Capital Advisory sold 6 Immatics shares in Q4 2024, an estimated $69.
  • American Capital Advisory first reported a position in Immatics in Q3 2024 and held it in 1 quarter.
  • American Capital Advisory's Immatics position peaked at $69 in Q3 2024.
  • 85 funds tracked by Wall St. Rank held Immatics as of Q4 2024.

Based on American Capital Advisory's 13F filing for Q4 2024, filed 28 Jan 2025.